Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Uptravi“
Suchtreffer
Begriffe & Kennungen
Uptravi · 4.5 · Transporter inhibitors (lopinavir/ritonavir) In the presence of 400 mg/100 mg lopinavir/ritonavir twice daily,
Eintrag öffnenUptravi · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenUptravi · 4.8 Undesirable effects · 1
Eintrag öffnenUptravi · 4.8 · 10 Hypotension In the phase 3 placebo-controlled study in patients with PAH, hypotension was reported for 5.8%
Eintrag öffnenUptravi · 4.8 · 9 Description of selected adverse reactions
Eintrag öffnenUptravi · 4.8 · Adverse reactions obtained from the pivotal clinical GRIPHON study and post-marketing surveillance are tabulat
Eintrag öffnenUptravi · 4.8 · Dyspepsia In a phase 3 placebo-controlled study in patients newly diagnosed with PAH, dyspepsia was reported w
Eintrag öffnenUptravi · 4.8 · Haemoglobin decrease In a phase 3 placebo-controlled study in patients with PAH, mean absolute changes in haem
Eintrag öffnenUptravi · 4.8 · In a phase 3 placebo-controlled study in patients newly diagnosed with PAH, mean absolute changes in haemoglob
Eintrag öffnenUptravi · 4.8 · Increase in heart rate In the phase 3 placebo-controlled study in patients with PAH, a transient increase in m
Eintrag öffnenUptravi · 4.8 · Long-term safety Of the 1 156 patients who participated in the pivotal study, 709 patients entered a long-term
Eintrag öffnenUptravi · 4.8 · Pharmacological effects associated with titration and maintenance treatment Adverse reactions associated with
Eintrag öffnenUptravi · 4.8 · Prostacyclin-like associated Titration Maintenance adverse reactions Selexipag Placebo Selexipag Placebo Heada
Eintrag öffnenUptravi · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenUptravi · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenUptravi · 4.8 · Summary of the safety profile
Eintrag öffnenUptravi · 4.8 · System organ class Very common Common Uncommon Blood and lymphatic Anaemia* disorders Haemoglobin decreased* E
Eintrag öffnenUptravi · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenUptravi · 4.8 · The most commonly reported adverse reactions are headache, diarrhoea, nausea and vomiting, jaw pain, myalgia,
Eintrag öffnenUptravi · 4.8 · The safety of selexipag has been evaluated in a long-term, phase 3 placebo-controlled study enrolling 1 156 ad
Eintrag öffnen